A detailed history of Advisor Net Financial, Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Advisor Net Financial, Inc holds 60,206 shares of PACB stock, worth $105,962. This represents 0.01% of its overall portfolio holdings.

Number of Shares
60,206
Previous 43,318 38.99%
Holding current value
$105,962
Previous $59,000 72.88%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$1.2 - $2.17 $20,265 - $36,646
16,888 Added 38.99%
60,206 $102,000
Q2 2024

Jul 16, 2024

BUY
$1.36 - $3.65 $8,803 - $23,626
6,473 Added 17.57%
43,318 $59,000
Q1 2024

Apr 12, 2024

BUY
$3.52 - $9.59 $4,664 - $12,706
1,325 Added 3.73%
36,845 $138,000
Q4 2023

Jan 19, 2024

BUY
$5.97 - $10.36 $39,264 - $68,137
6,577 Added 22.72%
35,520 $348,000
Q3 2023

Oct 12, 2023

BUY
$8.23 - $13.93 $279 - $473
34 Added 0.12%
28,943 $241,000
Q2 2023

Jul 14, 2023

BUY
$9.97 - $14.05 $1,964 - $2,767
197 Added 0.69%
28,909 $384,000
Q1 2023

Apr 28, 2023

BUY
$7.94 - $12.02 $992 - $1,502
125 Added 0.44%
28,712 $332,000
Q4 2022

Jan 13, 2023

BUY
$5.67 - $11.2 $2,976 - $5,880
525 Added 1.87%
28,587 $0
Q2 2022

Jul 07, 2022

BUY
$4.02 - $10.43 $5,587 - $14,497
1,390 Added 5.21%
28,062 $124,000
Q4 2021

Jan 19, 2022

SELL
$19.26 - $30.08 $22,726 - $35,494
-1,180 Reduced 4.24%
26,672 $546,000
Q3 2021

Oct 15, 2021

SELL
$24.86 - $35.02 $17,402 - $24,514
-700 Reduced 2.45%
27,852 $712,000
Q2 2021

Jul 06, 2021

SELL
$22.3 - $36.02 $10,927 - $17,649
-490 Reduced 1.69%
28,552 $998,000
Q1 2021

Apr 14, 2021

SELL
$26.38 - $51.15 $120,635 - $233,908
-4,573 Reduced 13.6%
29,042 $967,000
Q4 2020

Feb 04, 2021

SELL
$10.5 - $28.5 $172,252 - $467,542
-16,405 Reduced 32.8%
33,615 $872,000
Q3 2020

Nov 06, 2020

SELL
$3.61 - $9.87 $28,627 - $78,269
-7,930 Reduced 13.68%
50,020 $494,000
Q2 2020

Aug 26, 2020

BUY
$2.65 - $4.03 $50,350 - $76,570
19,000 Added 48.78%
57,950 $200,000
Q1 2020

May 14, 2020

BUY
$2.36 - $5.26 $5,900 - $13,150
2,500 Added 6.86%
38,950 $119,000
Q3 2019

Oct 23, 2019

BUY
$4.99 - $6.16 $27,445 - $33,880
5,500 Added 17.77%
36,450 $188,000
Q2 2019

Jul 15, 2019

BUY
$5.92 - $7.41 $62,456 - $78,175
10,550 Added 51.72%
30,950 $187,000
Q2 2018

Jul 27, 2018

BUY
$2.11 - $3.92 $16,458 - $30,576
7,800 Added 61.9%
20,400 $72,000
Q1 2018

May 08, 2018

BUY
$2.05 - $3.23 $20,500 - $32,300
10,000 Added 384.62%
12,600 $26,000
Q4 2017

Feb 27, 2018

BUY
$2.59 - $5.44 $6,734 - $14,144
2,600
2,600 $7,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $396M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.